ARWEN and LOGEX
ARWEN is a method created by LOGEX to unlock the value of real-world data by connecting forward-thinking hospitals and clinicians to a network that enables benchmarking, promotes collaboration and facilitates the sharing of treatment insights across different healthcare systems.
You can now find all information about ARWEN and LOGEX’s real-world evidence projects on the LOGEX website.
Read all about our pan-European Healthcare Observatories
Respiratory Tract Infectious Disease Observatory
Our European Infectious Disease Observatory provides real-world insights to support evidence-based decision-making:
Treatment Insights: Analyse the impact of historic and current use of vaccines, immunisations, and other therapies.
Patient Pathway Analysis: Explore associations between patient characteristics and treatment choices, evaluating their impact on clinical outcomes.
Healthcare Resource Utilisation: Compare resource use in hospitalised patients, evaluating differences between vaccinated and unvaccinated groups.
Immune Mediated Inflammatory Diseases Observatory
We provide valuable real-world insights into the treatment and management of inflammatory diseases across Europe:
Treatment Insights: Monitor patient pathways for those starting advanced systemic therapy, evaluating treatment effects.
Patient Pathway Analysis: Assess associations between demographics and treatment choices, compare patient cohorts, and evaluate compliance with national and local guidelines.
Healthcare Resource Utilisation: Analyse treatment patterns, drug uptake across countries, and resource use to optimise patient care and reduce unwarranted variation.
Solid Cancer Observatory
Our European Oncology Observatory provides real-world evidence to enhance treatment accessibility, affordability, and clinical effectiveness:
Treatment Insights: Track the uptake and usage of oncology treatments across multiple indications, assessing their impact.
Patient Pathway Analysis: Examine how patient characteristics influence treatment choices, compare real-world drug effectiveness, and evaluate compliance with clinical guidelines.
Healthcare Resource Utilisation: Assess hospital resource use, treatment costs, and variations in oncology care to support better decision-making.
Frequently asked questions
How is ARWEN connected to LOGEX?
ARWEN was developed as a method by LOGEX to support the structured use of real‑world data for healthcare insight generation. Since the method has now been fully established, it has now fully been integrated into the LOGEX RWE portfolio and its way of working.
Are there any implications for ARWEN?
ARWEN continues as a trusted method for safely connecting forward-thinking hospitals and clinicians to a network that enables benchmarking, promotes collaboration and facilitates the sharing of treatment insights across different healthcare systems. . The ARWEN method is used within the LOGEX Healthcare Observatories centred around specific therapeutic areas, specifically RTIs, IMIDs and Solid Cancers.
Are there any changes to existing ARWEN collaborations?
All ARWEN project agreements have always been with LOGEX, so there are no changes to any of the agreements or the ways of working.
How does LOGEX work with hospitals across Europe?
LOGEX collaborates with hospitals and clinicians in multiple European countries on collecting, harmonising, validating and analysing real‑world healthcare data within a structured and standardised framework (the ARWEN method). These collaborations enable comparative insights to participating hospitals, and shared leaning on aggregated, anonymised basis.
Where can I find more information about LOGEX’s RWE work ?
Please visit the LOGEX website for more information about our projects, results and insights.